AQR Capital Management’s CORMEDIX INC WTS EXP 04/30/15 CRMD.WS Stock Holding History

AQR Capital Management’s Portfolio CRMD.WS Stock Details CRMD.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-97,150	Closed	-$8K	–	2499
2014 Q4	$8K	Hold	97,150	–	–	﹤0.01%	2504
2014 Q3	$39K	Hold	97,150	–	–	﹤0.01%	2489
2014 Q2	$49K	Hold	97,150	–	–	﹤0.01%	2497
2014 Q1	$64K	Hold	97,150	–	–	﹤0.01%	2533
2013 Q4	$15K	Hold	97,150	–	–	﹤0.01%	2554
2013 Q3	$11K	Sell	97,150 -47,850	-33%	-$4.96K	﹤0.01%	2468
2013 Q2	$33K	Buy	+145,000	New	+$23.1K	﹤0.01%	2323

Other funds holding CRMD.WS

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

ICM

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AQR Capital Management's CRMD.WS Position: Q1 2015 in Review

AQR Capital Management sold out of CORMEDIX INC WTS EXP 04/30/15 (CRMD.WS) in Q1 2015, closing a stake of 97,150 shares — an estimated $8K sold.

AQR Capital Management first reported a position in CRMD.WS in Q2 2013 and held it in 7 quarters. The position peaked at $64K in Q1 2014. 4 funds tracked by Wall St. Rank hold CRMD.WS as of Q1 2015.

AQR Capital Management reported no remaining CORMEDIX INC WTS EXP 04/30/15 position as of Q1 2015 after selling out during the quarter.
AQR Capital Management sold 97,150 CORMEDIX INC WTS EXP 04/30/15 shares in Q1 2015, an estimated $8K.
AQR Capital Management first reported a position in CORMEDIX INC WTS EXP 04/30/15 in Q2 2013 and held it in 7 quarters.
AQR Capital Management's CORMEDIX INC WTS EXP 04/30/15 position peaked at $64K in Q1 2014.
4 funds tracked by Wall St. Rank held CORMEDIX INC WTS EXP 04/30/15 as of Q1 2015.

Based on AQR Capital Management's 13F filing for Q1 2015, filed 15 May 2015.